Haemorrhagic shock (60 min) in the anaesthetized rat resulted in a '/> Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis
首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis
【2h】

Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis

机译:硫化氢在大鼠失血性休克中的作用:硫化氢生物合成抑制剂的保护作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">Haemorrhagic shock (60 min) in the anaesthetized rat resulted in a prolonged fall in the mean arterial blood pressure (MAP) and heart rate (HR).Pre-treatment (30 min before shock) or post-treatment (60 min after shock) with inhibitors of cystathionine γ lyase (CSE; converts cysteine into hydrogen sulphide (H2S)), dl-propargylglycine or β-cyanoalanine (50 mg kg−1, i.v.), or glibenclamide (40 mg kg−1, i.p.), produced a rapid, partial restoration in MAP and HR. Neither saline nor DMSO affected MAP or HR.Plasma H2S concentration was elevated 60 min after blood withdrawal (37.5±1.3 μm, n=18 c.f. 28.9±1.4 μm, n=15, P<0.05).The conversion of cysteine to H2S by liver (but not kidney) homogenates prepared from animals killed 60 min after withdrawal of blood was significantly increased (52.1±1.6 c.f. 39.8±4.1 nmol mg protein−1, n=8, P<0.05), as was liver CSE mRNA (2.7 ×). Both PAG (IC50, 55.0±3.2 μm) and BCA (IC50, 6.5±1.2 μm) inhibited liver H2S synthesizing activity in vitro.Pre-treatment of animals with PAG or BCA (50 mg kg−1, i.p.) but not glibenclamide (40 mg kg−1, i.p., KATP channel inhibitor) abolished the rise in plasma H2S in animals exposed to 60 min haemorrhagic shock and prevented the augmented biosynthesis of H2S from cysteine in liver.These results demonstrate that H2S plays a role in haemorrhagic shock in the rat. CSE inhibitors may provide a novel approach to the treatment of haemorrhagic shock.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 麻醉大鼠的失血性休克(60分钟)导致平均动脉血压(MAP)和心率(HR)持续下降。 治疗前(休克前30分钟)或术后用胱硫醚γ裂解酶(CSE;将半胱氨酸转化为硫化氢(H2S)),dl-炔丙基甘氨酸或β-氰丙氨酸(50 mg kg -1 ,iv)进行治疗(休克后60分钟),或格列本脲(40 mg kg -1 ,ip),可使MAP和HR快速,部分恢复。生理盐水和DMSO均不影响MAP或HR。抽血后60分钟血浆H2S浓度升高(37.5±1.3μm,n = 18 cf 28.9±1.4μm,n = 15,P <0.05)。 从采血后60分钟处死的动物制备的肝脏(而非肾脏)匀浆将半胱氨酸转化为H2S的比例显着增加(52.1±1.6 cf 39.8±4.1 nmol mg蛋白 -1 ,n = 8,P <0.05),肝脏CSE mRNA(2.7×)也是如此。 PAG(IC50,55.0±3.2μm)和BCA(IC50,6.5±1.2μm)均在体外抑制肝脏H2S的合成活性。 用PAG或BCA(50 mg kg −1 ,ip)而不是格列苯脲(40 mg kg −1 ,ip,KATP通道抑制剂)消除了60分钟失血性休克动物血浆H2S的升高并阻止了这些结果表明,H2S在大鼠失血性休克中起作用。 CSE抑制剂可能为出血性休克的治疗提供一种新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号